Objectives To examine the effect of a community health worker (CHW) intervention, augmented by tailored text messages, on adherence to hydroxyurea therapy in youths with sickle cell disease, as well as on generic and diseasespecific health-related quality of life (HrQL) and youth-parent self-management responsibility concordance.
S
ickle cell disease is an inherited disorder that affects approximately 100 000 Americans, most commonly in persons of African American and Latino race/ethnicity. 1, 2 The disease is associated with chronic anemia, pain, and organ dysfunction, leading to multiple acute and chronic complications, high healthcare utilization, 3, 4 premature mortality, 5 and poor quality of life. 6, 7 Hydroxyurea, the first US Food and Drug Administration-approved drug for sickle cell disease therapy, reduces hospitalization 8, 9 and improves quality of life 10, 11 in youths with sickle cell disease. Since 2014, national guidelines have recommended the use of hydroxyurea 12, 13 for most children with the severe phenotypes of homozygous sickle cell disease and the compound heterozygous condition of hemoglobin S-b 0 thalassemia. Nonetheless, hydroxyurea remains an underused therapeutic option. [14] [15] [16] The self-management roles of youths and parents change throughout childhood and adolescence with self-management responsibility transitioning from parents to youths. Adolescence is a critical time to optimize adherence to chronic drug therapy because treatment adherence often deteriorates during this time 17 as youths assume greater responsibility for their self-care. As for adolescents with other chronic conditions, 18 adherence to a daily drug regimen is suboptimal for many youths prescribed hydroxyurea. 14, [19] [20] [21] Across age groups, older adolescents and young adults with sickle cell disease have the highest rate of hospitalization, 22 highlighting the importance of interventions to improve health status in this age group.
Ideally, during adolescence, the transfer of developmentally appropriate selfmanagement responsibility occurs over time, with parents remaining involved in
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Health-related quality of life MCID Minimal clinically important difference a supportive role. 23 This often is not the case, however. A recent systematic review reported data synthesized from 28 studies that examined adherence barriers from the perspective of adolescents with chronic health conditions. 24 Across studies, a salient theme in nonadherence was adolescent-parent conflict, stemming from either the parent's difficulty with delegation of self-management responsibility or the adolescent's perception of lack of parental support. Maintaining communication between parents and youths regarding self-management is key. The use of community health workers (CHWs) has been successful in helping adults with chronic illness improve their self-management. [25] [26] [27] To date, there have been few reports on CHW support of adolescents 28 or patients with sickle cell disease. 29 We hypothesized that a 6-month CHW intervention, augmented by text messages to help parent-youth dyads formulate a daily hydroxyurea habit (the Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment [HABIT] 30 study; ClinicalTrials.gov: NCT02029742) would be feasible, acceptable to youth-parent dyads, and provide data for estimating an effect size for improving hydroxyurea adherence. Here we report the effects of the HABIT intervention on secondary outcomes, specifically the change in youths' HrQL from the perspectives of parents and youths, and dyad concordance regarding self-management responsibility. Although HrQL is higher in youths who receive hydroxyurea therapy compared with those who do not, 11 little is known about how changes in hydroxyurea adherence is related to self-and parent-proxy reported HrQL.
Methods
The HABIT study design has been described previously. 30, 31 This 2-site, 6-month randomized controlled trial was conducted to test the intervention's feasibility and acceptability and to estimate the effect of a CHW intervention for youthparent dyads-augmented by tailored text messages-to improve hydroxyurea adherence among youths with sickle cell disease. A computer-generated randomization scheme with a 2:1 allocation to the intervention group was used. Dyads randomized to the intervention were contacted by the CHW to schedule visits either at home or another location based on dyad preference. Both groups received educational handouts about sickle cell disease and hydroxyurea therapy and usual clinical care at monthly intervals. Institutional Review Board approval was obtained at each participating site before study initiation.
Subjects were recruited between September 4, 2013, and March 28, 2015, from 2 pediatric sickle cell disease programs at academic medical centers in New York City. Both centers serve a diverse population. Potentially eligible youths with sickle cell disease were identified by a review of their history of hydroxyurea therapy, including highest hemoglobin F (HbF) value following hydroxyurea induction (considered the youth's "personal best" HbF 21 ) compared with the average of 3 HbF levels obtained over the previous 12 months.
Those with an average HbF value of ≤10% of their personal best were eligible for study participation if they also met all the other study inclusion criteria, as described elsewhere.
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Study Procedures
Following parental informed consent and youth assent, dyads completed baseline questionnaires, youths provided a blood sample for HbF assessment, and dyads were randomized to study group. Each intervention dyad member lacking a personal cell phone received a phone for use during the study. Dyads completed 7 monthly clinic visits (months 0-6) for survey completion and HbF assessment. Intervention dyads met with CHWs an average of 4.9 ± 0.9 times during the first 3 study months. The majority of CHW visits were conducted at the subjects' homes. Each visit had a specific focus, such as an initial intake visit to identify pressing social issues, such as housing or mental health (visit 1); a visit to identify and address barriers to hydroxyurea use, such as an incomplete understanding of benefits or adverse effects or forgetting the daily dose (visit 2); a visit to discuss the delegation of, and satisfaction with, level of responsibility for self-management tasks (visit 3); and a visit to identify a habit on which hydroxyurea adherence could be built, such as toothbrushing, dinner time, or bedtime (visit 4).
During the first 2 visits, CHWs reviewed educational handouts for sickle cell disease and hydroxyurea with the parents and youths. Although each visit was structured, CHWs had the ability to be flexible to accommodate dyad needs. In collaboration with their CHWs, parents and youths each developed text message language to remind them to take daily hydroxyurea, tailored by wording of message, language (Spanish or English), and time of text message delivery (visit 5). At month 4, dyads transitioned from CHW visits to receipt of daily text messages for the duration of the study. CHWs met with study investigators biweekly to review visits, referrals made, and any concerns about dyad progress, as well as to assess ongoing fidelity to the protocol. If a "red flag" issue (eg, suicidal ideation) was identified during a home visit, then the CHW contacted the study's principal investigator for immediate guidance and/or confirmation of the plan. Two CHWs covered the subjects at both sites.
Study Outcomes and Measures
The primary outcome-improved hydroxyurea adherencewas measured by monthly progress of the biomarker HbF toward a patient's personal best, by the proportion of days covered by hydroxyurea using pharmacy prescription records, 32 and by the 4-item Morisky scale. 33 Each measure in the study protocol has been described previously, 31 and an assessment of the primary outcomes has been reported recently. 34 Secondary outcomes of the study were generic-and disease-specific HrQL and dyad concordance regarding selfmanagement responsibility. Youths and parents completed survey measures at months 0, 3, and 6 in either English or Spanish based on individual preference.
The PedsQL Generic Core Scale, a 23-item, 5-point Likert scale measure, was used to measure generic HrQL. The THE JOURNAL OF PEDIATRICS • www.jpeds.com Volume 197 • June 2018 instrument, available in both English and Spanish, has 4 subscales and has demonstrated high internal consistency for both the full instrument and its subscales. 35 It has been widely used in patients with sickle cell disease. 11, [36] [37] [38] In this study, we used youth-and parent proxy-report instruments for age 8-12 years and age 13-17 years. A PedsQL total score of ≤60 can be interpreted as impaired quality of life, whereas a score ≥80 is consistent with good quality of life 39 in youths with sickle cell disease.
The PedsQL Sickle Cell Disease Module, a 43-item, 5-point Likert scale measure, was used to measure disease-specific HrQL. Internal consistency ranges from acceptable to high for the instrument and its 9 subscales. 40 Two subscales address worry (Worry I, concern about pain and hospitalization; Worry II, concern about stroke and/or chest crisis), and 2 subscales address communication (Communication I, communicating with the health care team; Communication II, difficulty communicating when others do not understand the impact of living with sickle cell disease). Similar to the PedsQL Generic Core Scale, youth and parent proxy reports were used for both age groups. Scores for the PedsQL and PedsQL Sickle Cell Disease Module range from 0 to 100, with higher scores indicating perception of better quality of life. Both generic and diseasespecific HrQL measures are sensitive to changes in clinical status over time in youths with sickle cell disease. [41] [42] [43] Recently, the longitudinal validity and estimations of change in PedsQL Sickle Cell Disease Module scores that can be interpreted as clinically meaningful were established using data from a sample of youths who participated in a multisite clinical trial. 44 The Sickle Cell Family Responsibility Scale (SCFRS), adapted from the Diabetes Family Responsibility Questionnaire, 45 is a 10-item 3-point Likert scale questionnaire that examines the perception of both youth and parent regarding who takes responsibility for sickle cell disease self-management tasks. This scale was used to measure level of self-management responsibility and dyad concordance regarding self-management responsibility. The Diabetes Family Responsibility Questionnaire has been widely adapted for use in other pediatric chronic diseases, including asthma, 46 inflammatory bowel disease, 47 and HIV infection. 48 Scores on the SCFRS range between 10 and 30, with higher scores indicating greater youth responsibility and lower scores indicating greater parent responsibility for self-management tasks. Dyad self-management concordance 49 was measured as the number of self-management tasks for which both the youth and the parent agreed. Scores range between 0 and 10, with higher scores indicating greater dyad agreement.
When instruments were unavailable in Spanish, the English language version underwent a forward and backward translation process supervised by the Columbia University Medical Center's Spanish Translation Center. Following verification of the translated version, the instrument was piloted with Spanishspeaking subjects. The PedsQL Sickle Cell Disease Module underwent an additional step in the linguistic validation process. 50 Ten Spanish-speaking youth-parent dyads completed the Spanish language youth or parent proxy version of the questionnaire for youths aged either 8-12 years (5 dyads) or 13-17 years (5 dyads). Following survey completion, each dyad member participated in a cognitive interview to determine whether questionnaire directions, questions, and response choices were clear, relevant to those with sickle cell disease, appropriate, and easily understood.
Statistical Analyses
An internal consistency reliability or Cronbach a coefficient was computed for each baseline measure and its subscales to determine scale reliability in our sample. An a value ≥0.70 was considered to indicate adequate reliability. 51 Descriptive statistics were used to profile outcome measures at each data collection point for the intervention and control groups. Group differences at baseline were examined using the Wilcoxon signed-rank test. We computed a minimal clinically important difference (MCID) of each total and subscale score, calculated as the standard error of measurement (d √1 − a), 52 as a criterion for assessing clinically meaningful improvement as a result of the intervention. An individual growth model, 53 a type of linear mixed model with random intercepts, was used to examine the difference in each outcome incorporating group assignment and study month. Using the estimated b value of the time × intervention interaction and its corresponding standard error, we compared the difference in score from baseline to 6 months to its respective MCID to assess whether the change in score at 6 months represented a clinically meaningful change. To account for multiple tests, we conducted the Benjamini-Hochberg procedure 54 to adjust for false discovery. All subject data were used in the analyses. Data were analyzed using SAS 9.4 statistical software (SAS Institute, Cary, North Carolina).
Results
Demographic characteristics of the sample and effect of the intervention on primary outcomes have been reported previously. 34 In brief, 28 youth-parent dyads (mean age of youths, 14.3 ± 2.6 years; 50% Hispanic) participated (18 intervention dyads and 10 control dyads) with 10.7% dyad attrition at month 6 (2 intervention dyads and 1 control dyad). Most (12 of 14) the Hispanic parents and one-half (7 of 14) of the Hispanic youths completed self-report measures in Spanish. Dyads were enrolled between October 2013 and March 2015. One in 4 intervention subjects (3 parents and 6 youths) needed a mobile telephone for participation in the texting component of the intervention. The intervention was feasible and intervention subjects enjoyed working with the CHWs. Incorporating group assignment and time, intervention subjects progressed to a personal best HbF by 2.3% per month during months 0 to 4 (P = .30). Four subjects (3 intervention, 1 control) exceeded their historical personal best HbF by study completion. The Figure provides additional details regarding dyad recruitment and enrollment, group allocation, subject attrition, and subjects included in the analysis. Table I (available at www.jpeds.com) provides details regarding the number of subjects eligible for survey completion at each time point. Table II compares HrQL, self-management responsibility, and dyad concordance regarding responsibility of the intervention and control groups at study entry. The internal consistency of each survey measure in this sample was acceptable for both youth and parent measures, with Cronbach a values ranging between 0.75 and 0.92 for total scores and between 0.71 and 0.96 for subscale scores for all but the Worry II subscale (a = 0.66) of the PedsQL Sickle Cell Disease Module youth measure. At study entry, compared with control youths, intervention youths reported significantly lower scores for generic HrQL total score (mean, 71.8 ± 17.7 vs 85.8 ± 11.6; P = .03) and its Emotional subscale (mean, 71.4 ± 22.5 vs 90.0 ± 9.4; P = .02). There were no other differences in youth or parent-proxy reported scores. Overall, generic HrQL total scores were higher than disease-specific HrQL scores, with youth-reported scores higher than parent proxy-reported scores. Regarding generic HrQL subscale scores, the School subscale was rated lowest by both youths and parents (68.4 ± 22.8 and 57.8 ± 28.0, respectively). Of the disease-specific subscales, youths and parents rated Pain Impact (57.6 ± 33.6 and 51.1 ± 27.3, respectively) and Pain Management (56.7 ± 33.6 and 58.9 ± 33.9, respectively) the lowest. Regarding sickle cell disease self-management responsibility, youths reported having greater responsibility compared with their parents (20.1 ± 5.0 and 15.3 ± 3.6, respectively). On average, dyads were concordant regarding who takes responsibility for approximately one-half (4.4 ± 2.5) of the 10 self-management tasks, with no differences between the groups.
Table II also presents MCIDs for youth-and parent proxyreported total and subscale scores for each instrument. These values suggest that a change in score of 4.8 points in the youthreported generic HrQL total score is a clinically meaningful difference. Similarly, based on this sample, a change in score of 5.5 points in the parent proxy-reported generic HrQL total score is a clinically meaningful difference. Overall, MCIDs ranged between 2.5 (self-management responsibility) to 14.6 (Worry II disease-specific HrQL subscale) for youth-reported measures and between 1.8 (self-management responsibility) and 11.4 (Worry II subscale) for parent-proxy reported measures.
Table III (available at www.jpeds.com) reports HrQL and self-management responsibility scores for youths and parents at 0, 3, and 6 months. At 6 months, intervention youths reported improvements in total score and 3 subscale scores (Physical, School, and Emotional), whereas control youth scores either decreased (total score, School and Emotional subscales) or remained stable (Physical subscale). For youth-reported disease-specific HrQL, at 6 months intervention youths had improved in all scores, whereas the majority of control youths either remained stable (total score, Pain Impact, Treatment, Communication I, and Communication II subscales) or declined (Pain Management and Emotions subscales). For parent proxy-reported generic and disease-specific HrQL, at 6 months both intervention and control parents reported higher scores for all measures except the Emotional subscale of generic HrQL. For this subscale, while intervention parents reported higher scores over the 6 month period, scores of control parents remained stable. Table IV (available at www.jpeds.com) presents findings of the individual growth model analyses for parent-and youthreported outcomes. Incorporating group assignment and time and controlling for false discovery, compared with the control youths, intervention youths had greater increases in the generic HrQL total score (9.8 points; 95% CI, 0.4-19.2) and its Emotional (15.0 points; 95% CI, 1.6-28.4) and School subscales (14.1 points; 95% CI, 1.4-29.6) from month 0 to month 6. Regarding disease-specific HrQL, at 6 months the intervention youths had a greater increase than the control youths in 3 subscales: Worry I (worried less about pain and need for hospitalization or emergency room visits; 30.0 points; 95% CI, 8.5-51.5); Emotions (less anger about having sickle cell disease; 37.0 points; 95% CI, 9.4-64.5); and Communication I (easier to talk to others, including health professionals, about how they feel; 17.8 points; 95% CI, 0.5-35.1). Although there was a trend toward improvement in dyad concordance regarding self-management responsibility at 3 months (3.5 points; 95% CI, −0.2 to 7.1), there were no differences at 6 months. There were no differences in parent-reported generic or disease-specific quality of life measures.
Table V presents the HrQL score change and its respective 95% CI from study entry to 6 months for each measure and 
Discussion
In this feasibility study, youth-parent dyads randomized to the HABIT intervention exhibited improvements in some, but not all, secondary outcomes. Sample HrQL scores at baseline were similar to those in other reports of youths receiving hydroxyurea, 11 with MCIDs for generic and disease-specific HrQL estimated from this sample similar to that of other samples of youths with sickle cell disease. 44 At 6 months, there was a trend toward improvement in youth-reported HrQL scores for the generic HrQL total score and Emotional and School subscales, as well as in 3 of the 9 subscales of the diseasespecific HrQL measure: Worry I, Emotions, and Communication I, and dyad concordance regarding self-management responsibility at 3 months. In most cases, the score improvement exceeded that of its respective MCID. These findings suggest that the magnitude of improvement in these areas of HrQL was clinically meaningful to the youths. Although these magnitudes were not statistically significant when controlled for multiple comparisons, this feasibility study was not powered to detect changes at that level.
Although support for chronic disease self-management in adults with chronic disease is well established, it remains underused in pediatric care. 55 In this study, CHWs provided support to youth-parent dyads with the goal of improving hydroxyurea adherence. Improvements in youth-reported HrQL centered on psychosocial domains: emotions, worry and communication. It might not be surprising that these HrQL domains were affected in a positive way, because the HABIT intervention specifically focused on hydroxyurea adherence barriers and improving parent-youth partnerships in selfmanagement responsibility. Discussions with the CHW might have served as a catalyst for dyad conversations about their evolving roles and responsibilities in self-management, specifically hydroxyurea adherence and barriers acknowledged and addressed. What remains uncertain is whether trends in improvement in youth-reported HrQL can be attributed to the process of improving hydroxyurea adherence with support provided by CHWs or to improved dyad concordance regarding self-management responsibility. Of 17 studies included in a systematic review of randomized trials that examined the use of lay health worker interventions for youths with chronic disease, 28 only 1 study 56 examined youth HrQL as an outcome. In that study, HrQL assessment was measured solely by parent proxy report and demonstrated no differences between groups at 12 months. Further research is needed regarding the impact of CHW interventions on HrQL of youths with sickle cell disease, as well as youths with other chronic conditions.
Adolescents are expected to increasingly take on responsibility for self-management tasks. During this transfer, if the youth and the parent each assume that the other is responsible for a self-care task, then neither one may take responsibility for the task, and self-management is compromised. For example, parent-youth discordance has been associated with 57 For dyads randomized to the HABIT intervention, concordance between the youth and the parent regarding who was responsible for different aspects of sickle cell disease self-management showed a trend toward improvement at 3 months. However, this trend was not sustained at 6 months when text message reminders were the primary means of hydroxyurea adherence support. The CHW component of the intervention may have been too brief for dyads to develop sustained concordance. CHW interventions with parents and children to improve asthma medication adherence have tended to be fully supportive for 6 months before a reduced level of support is seen. 58 Further research is warranted to examine dyad selfmanagement responsibility concordance over time and whether it serves as a moderator of hydroxyurea adherence in youths with sickle cell disease.
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Evidence is accumulating from multisite randomized controlled trials examining the effect of interventions on HrQL outcomes in youths with sickle cell disease. [59] [60] [61] [62] Although these trials are limited in number, the majority have examined the effects of therapeutic interventions, such as blood transfusion therapy, 59 interventions to alleviate pain crises, 60 and vitamin supplementation. 61 Two studies 60, 61 failed to detect a treatment effect on either the primary or HrQL outcomes. Only one study, 59 an intervention of chronic blood transfusions, found improvement in several physical health domains of the generic HrQL Child Health Questionnaire at 36 months. Similar to our findings, domain improvements in HrQL were consistent with the type of intervention tested.
A fourth study, 62 a multisite family-based behavioral intervention delivered at home, aimed to improve school functioning for youths aged 6-12 years with sickle cell disease. There were no differences in HrQL or other study outcomes. In the HABIT study, although home visits often required scheduling after school hours or weekend days, dyad members engaged with the CHWs with high subject retention at 6 months.
Our findings must be considered in light of the study's limitations. The sample size was relatively small, and so the study had limited statistical power. Despite randomization, there were group differences in some youth-reported generic HrQL scores at study entry. Further, although intervention youth-reported scores in some HrQL domains increased, those reported by the control group declined and might have influenced the interpretation of score change compared with MCIDs. Subjects and study investigators were not blinded to study group assignment, although allocation concealment was maintained. Study clinic visits were more frequent than usual for youths prescribed hydroxyurea, currently every 2-3 months. The 6-month intervention may have been too brief to test its full impact on primary and secondary outcome measures. The SCFRS measure was adapted from a frequently used diabetes measure and had not been formally tested with parents and youths with sickle cell disease before its use in this study. Despite these limitations, these findings add to a growing literature of HrQL outcomes for youths with sickle cell disease.
In summary, this trial has demonstrated that the HABIT intervention is feasible and shows promise in improving psychosocial domains of both generic and disease-specific HrQL, as well as dyad concordance regarding self-management tasks. Testing intervention efficacy and outcome sustainability in a larger 4-site intervention trial is underway. Interventions to improve hydroxyurea adherence have the potential to improve the health of youths with sickle cell disease. Structured support provided by CHWs may be a beneficial adjunct to clinicbased care for improving chronic disease self-management of these youths. I n 1968, Gianantonio et al published long-term follow-up data on a retrospective cohort of 76 children who had survived an acute episode of hemolytic-uremic syndrome (HUS). The most common sequelae were hypertension, proteinuria, and chronic kidney disease. After resolution of HUS, two-thirds of patients fully recovered renal function, and the remainder either did not recover or recovered with subsequent progressive loss of kidney function. Children with poor outcomes often had evidence of active glomerulonephritis on renal biopsy, which suggested a different etiology of HUS and foreshadowed the tremendous advances that would be made in our understanding of the pathogenesis of HUS over the next one-half century.
HUS is now recognized as a manifestation of many different diseases, including infection with Shiga toxinproducing organisms, pneumococcal infection, cobalamin C deficiency, malignant hypertension, and glomerular diseases, but the leading cause of HUS is diarrheal illness from infection by Shiga toxin-producing Escherichia coli (STEC-HUS).
1 HUS also occurs as a primary disease due to overactivation of the alternative complement pathway (previously known as atypical HUS), which is caused by mutations in complement genes or complement factor H autoantibodies. 2 The clinical course and management of HUS differ with the underlying etiology. STEC-HUS is typically self-limited and has favorable long-term outcomes. Aggressive fluid management and dialysis are the cornerstone of STEC-HUS management. 1, 3 In contrast, complement-mediated HUS is characterized by a refractory course with frequent relapses, leading to progressive kidney damage and loss of renal function. Therefore, most of the patients with HUS identified by Gianantonio et al who fully recovered renal function likely had STEC-HUS, whereas those with progressive renal disease more likely had complement-mediated HUS. Notably, complement-mediated HUS now has a much better prognosis owing to the availability of eculizumab, a terminal complement inhibitor that induces rapid and durable remission. Bolded values represent estimated score change/month and its respective standard error attributed to the HABIT intervention. Time was defined as a numeric variable: time 0, baseline; time 1, 3 months; time 2, 6 months.
*Adjusted for multiple comparisons using the Benjamini-Hochberg procedure.
